Is OPKO Health a Diagnostics Stock Worth Buying?

Multinational biopharmaceutical company OPKO Health’s (OPK) stock climbed nearly 13% in price last year when the company announced its plans to acquire ModeX Therapeutics. However, given the company’s declining financials and negative profit margins, is it worth buying the stock now? Let’s discuss. shutterstock.com – StockNews OPKO Health Inc. (OPK) in Miami, Fla., is a…

The 5 Bald Faced Lies Told to Aspiring Entrepreneurs

Opinions expressed by Entrepreneur contributors are their own. It can take a lifetime to sort through all the truly horrible advice you’ll be told as you create your startup. Often these opinions are stated as facts, until someone proves them to be myths. For example, before 2014, the idea was that you simply couldn’t build…

Teladoc Health Stock is Pricing Right

Telehealth software company Teledoc Health (NYSE: TDOC) stock has collapsed from a post-pandemic high of $308 in Feb 2021 to a recent low of $27.38 in May 2022. To call this a tragedy for investors at the top would be an understatement. However, shares were trading in the $9s pre-pandemic in 2016. Telehealth stocks were…

DoubleVerify Holding Stock attempts a Double Bottom

Online advertising measurement firm DoubleVerify (NYSE: DV) stock has fallen (-36%) from its IPO highs in 2021. The bear market sell-off was brutal on the enterprise digital media monitoring platform. However, the Company has been grew at 43% in its record Q1 2022 top line and raised its fiscal 2022 revenue guidance in its fiscal…

Datadog: A Unicorn Cloud Stock

Datadog (NASDAQ: DDOG) is one of the market’s most successful cloud monitoring companies. It caught the attention of billionaire money managers and hedge funds last quarter with Ken Griffin’s Citadel Advisors, Overdeck and Siegel of Two Sigma, and Israel Englander’s Millennium Management showing they all bought shares in their 13F filings. These institutions were seemingly…